BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31106706)

  • 1. Effects of psoriasis treatment on genital warts: a case report.
    Campoli M; Cinotti E; Fimiani M; Pellegrino M; Tognetti L; Rubegni P
    Int J STD AIDS; 2019 Jul; 30(8):828-830. PubMed ID: 31106706
    [No Abstract]   [Full Text] [Related]  

  • 2. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
    Wald JM; Klufas DM; Strober BE
    J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
    J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine.
    Warren RB; Griffiths CE
    Clin Dermatol; 2008; 26(5):438-47. PubMed ID: 18755362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients.
    Cohen Barak E; Kerner M; Rozenman D; Ziv M
    Dermatol Ther; 2015; 28(3):126-30. PubMed ID: 25640261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials.
    Papp KA; Armstrong AW; Reich K; Karunaratne M; Valdecantos W
    Am J Clin Dermatol; 2016 Feb; 17(1):79-86. PubMed ID: 26547918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with psoriasis.
    Croney S
    Br J Nurs; 2017 Mar; 26(5):260-262. PubMed ID: 28328264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
    Sator P; Richter L; Saxinger W; Vasiljevic M; Stingl G
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
    Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
    Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab vs. etanercept in psoriasis.
    Downs AM
    Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
    Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
    J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cyclosporin in a child with generalized pustular psoriasis.
    Alli N; Güngör E; Karakayali G; Lenk N; Artüz F
    Br J Dermatol; 1998 Oct; 139(4):754-5. PubMed ID: 9892934
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine and tacrolimus in dermatology.
    Cather JC; Abramovits W; Menter A
    Dermatol Clin; 2001 Jan; 19(1):119-37, ix. PubMed ID: 11155577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of malignancy associated with cyclosporin use in psoriasis.
    Paul C; Hornig F
    Dermatology; 1999; 198(3):320-1. PubMed ID: 10419287
    [No Abstract]   [Full Text] [Related]  

  • 15. Childhood psoriasis: often favorable outcome.
    Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer treatment options for patients with moderate-to-severe psoriatic disease.
    Roebuck HL
    Nurse Pract; 2006 Aug; 31(8):5-6,11. PubMed ID: 16966969
    [No Abstract]   [Full Text] [Related]  

  • 17. Pemphigus vulgaris with plaque-type psoriasis successfully treated with cyclosporine monotherapy.
    Rallis E; Stavropoulos P; Christofidou E; Rigopoulos D; Koumantaki-Mathioudaki E
    Am J Clin Dermatol; 2011 Aug; 12(4):283-4. PubMed ID: 21668035
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
    Buell C; Koo J
    J Drugs Dermatol; 2008 Aug; 7(8):741-8. PubMed ID: 18720690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of methotrexate in patients with psoriasis.
    Kuhn A; Ruland V; Patsinakidis N; Luger TA
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S138-44. PubMed ID: 21044448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
    Nijsten T; Spuls PI
    Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.